Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

The Journal of Headache and Pain
Antonio RussoGioacchino Tedeschi

Abstract

erenumab was safe and effective in clinical trials for the prevention of migraine. However, real-life data are still lacking. Here we report the clinical experience from an Italian real-world setting using erenumab in patients with chronic migraine experiencing previous unsuccessful preventive treatments. Seventy patients with chronic migraine and failure to ≥4 migraine preventive medication classes initially received monthly erenumab 70 mg s.c. Patients without a clinically meaningful improvement, considered as a > 30% reduction in headache days per month, after ≥3 months of therapy switched to monthly erenumab 140 mg. At the first administration and after 3 and 6 months, patients underwent extensive interviews to assess clinical parameters of disease severity and migraine-related disability and impact, and validated questionnaires to explore depression/anxiety, sleep, and quality of life (QoL). Finally, the Pain Catastrophizing Scale, Allodynia Symptom Checklist-12 and MIGraine attacks-Subjective COGnitive impairments scale (MIG-SCOG) were administered. 70% of patients were "responders" after the third administration of erenumab 70 mg, whereas 30% switched to erenumab 140 mg; 29% (6 pts) responded after the sixth administrati...Continue Reading

References

Apr 6, 2001·The Clinical Journal of Pain·M J SullivanJ C Lefebvre
Dec 4, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M KosinskiS Tepper
Sep 6, 2007·Cephalalgia : an International Journal of Headache·K A HolroydV Heh
Feb 26, 2008·Cephalalgia : an International Journal of Headache·S SilbersteinUNKNOWN Task Force of the International Headache Society Clinical Trials Subcommittee
Oct 16, 2009·Cephalalgia : an International Journal of Headache·J C ColeM F T Rupnow
Feb 19, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·D C BuseR B Lipton
Feb 23, 2010·Lancet Neurology·Peter J Goadsby, Till Sprenger
Jun 25, 2010·Headache·Elisa SancisiPasquale Montagna
Sep 8, 2010·Cephalalgia : an International Journal of Headache·Min YangMark Kosinski
Jun 2, 2011·Cephalalgia : an International Journal of Headache·Raquel Gil-GouveiaIsabel Pavão Martins
Apr 25, 2012·Neurology·S D SilbersteinUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
May 18, 2012·The Journal of Headache and Pain·Paola SarchielliGiorgio Zanchin
Sep 26, 2012·The Journal of Headache and Pain·Sait AshinaDawn C Buse
Oct 2, 2013·Brain : a Journal of Neurology·Mark A LouterGisela M Terwindt
Sep 10, 2015·Cephalalgia : an International Journal of Headache·Raquel Gil-GouveiaIsabel Pavão Martins
Jun 16, 2016·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Yuanhao YangDale R Nyholt
Dec 3, 2016·Headache·Stephen D Silberstein
Aug 9, 2017·Current Pain and Headache Reports·Chun-Pai Yang, Shuu-Jiun Wang
Oct 25, 2017·Current Neurology and Neuroscience Reports·Antonio RussoAlessandro Tessitore
Nov 25, 2017·The New England Journal of Medicine·Peter J GoadsbyRobert A Lenz
Feb 3, 2018·The Journal of Headache and Pain·Zaza KatsaravaTimothy J Steiner
Feb 24, 2018·Cephalalgia : an International Journal of Headache·David W DodickRobert A Lenz
Apr 5, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Bianca Raffaelli, Uwe Reuter
Aug 10, 2018·Headache·Angeliki Vgontzas, Jelena M Pavlović
Nov 18, 2018·The Journal of Headache and Pain·Doga VuralliHayrunnisa Bolay
Jan 15, 2019·Current Pain and Headache Reports·Britany KlenofskyHuma U Sheikh
Jan 22, 2019·Cephalalgia : an International Journal of Headache·David W Dodick
Mar 31, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Piero BarbantiLuisa Fofi

❮ Previous
Next ❯

Citations

Sep 30, 2020·Headache·Shuli ChengElspeth Hutton
Aug 28, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Umberto PensatoSabina Cevoli
Aug 28, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Angelo RanieriValentino Manzo
Jan 6, 2021·International Journal of Environmental Research and Public Health·Domenico D'AmicoAlberto Raggi
Jan 8, 2021·The Journal of Headache and Pain·Ilaria FrattaleRaffaele Ornello
Mar 18, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Alicia AlpuentePatricia Pozo-Rosich
Apr 27, 2021·Frontiers in Neurology·Marcello SilvestroAntonio Russo
May 20, 2021·The Journal of Headache and Pain·Simona SaccoUNKNOWN Burden and Attitude to Resistant and Refractory (BARR) Study Group
May 22, 2021·Acta Neurologica Scandinavica·Marcello SilvestroAntonio Russo
Jul 17, 2021·Brain and Behavior·Carlo BaraldiSimona Guerzoni
Jul 19, 2021·The Journal of Headache and Pain·Robert BelvísMargarita Sánchez Del Río
Oct 14, 2021·Cephalalgia : an International Journal of Headache·Lucas Hendrik OvereemLars Neeb
Jan 11, 2022·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Austėja DapkutėKristina Ryliškienė
Dec 30, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Chiara ZeccaClaudio Gobbi
Jul 6, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Umberto PensatoSabina Cevoli

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02066415

Software Mentioned

LIBERTY
STATA
ARISE
STRIVE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.